We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
German pharmaceutical company Bayer has teamed with UK-based AI-enabled digital health solutions provider Salus Optima to help people with their healthy ageing process. The partnership aims to improve
US-based pharmaceutical company AbbVie has agreed to acquire Cerevel Therapeutics, a company focused on developing treatments for neuroscience diseases, for a total of $8.7bn. Cerevel has a pipeline
US-based pharmaceutical company AbbVie and biotechnology company BigHat Biosciences have partnered to discover and develop next-generation therapeutic antibodies in oncology and neuroscience. The research collaboration will leverage BigHat’s
Swiss pharmaceutical firm Roche has agreed to acquire Carmot Therapeutics, a US-based biotechnology company focused on therapeutics for people living with metabolic diseases. Under the terms of the
US-based pharmaceutical company Eli Lilly and Company (Lilly) has received the US Food and Drug Administration (FDA) approval for Jaypirca (pirtobrutinib), under its accelerated approval pathway. Jaypirca (pirtobrutinib),
AbbVie has agreed to acquire ImmunoGen, a biotechnology company developing antibody-drug conjugate (ADC) therapeutics to treat cancer, for a total equity value of around $10.1bn. Under the terms
Bristol Myers Squibb (BMS) and Avidity Biosciences have entered into a global licencing and research collaboration, worth up to $2.3bn, to discover, develop, and market multiple cardiovascular targets.
US-based biopharmaceutical company SpringWorks Therapeutics has received the US Food and Drug Administration (FDA) approval for Ogsiveo (nirogacestat) to treat a rare subtype of soft tissue tumours. Ogsiveo
Everest Medicines has received China’s National Medical Products Administration (NMPA) approval for Nefecon to treat primary immunoglobulin A nephropathy (IgAN) in adults, who are at risk of disease
US-based AI medical imaging platform Flywheel, in collaboration with Nvidia and Microsoft, has launched its software-as-a-service (SaaS) data management solution on Microsoft Azure. The SaaS platform is integrated